Olivier Morales
Overview
Explore the profile of Olivier Morales including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
579
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Trioen C, Soulier T, Massoud J, Bouchez C, Stoup N, Lefebvre A, et al.
Cancer Commun (Lond)
. 2025 Jan;
PMID: 39749695
No abstract available.
2.
Lefebvre A, Marhfor S, Baert G, Deleporte P, Grolez G, Boileau M, et al.
Biomedicines
. 2024 Sep;
12(9).
PMID: 39335633
Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. Despite new treatments, the HCC rate remains important, making it necessary to develop novel therapeutic strategies. Photodynamic therapy (PDT)...
3.
Devalckeneer A, Lu T, Bourgeois P, Maurage C, Loiez C, Grolez G, et al.
Neurosurg Rev
. 2024 Jul;
47(1):325.
PMID: 39001998
Introduction: The etiology of brain aneurysms remains poorly understood. Finnish research suggests that oral bacteria might contribute to the development and rupture of brain aneurysms. Previous studies by our team...
4.
Boidin L, Moinard M, Moussaron A, Merlier M, Morales O, Grolez G, et al.
J Control Release
. 2024 May;
371:351-370.
PMID: 38789088
Ovarian cancer (OC) is one of the most lethal cancers among women. Frequent recurrence in the peritoneum due to the presence of microscopic tumor residues justifies the development of new...
5.
Lefebvre A, Trioen C, Renaud S, Laine W, Hennart B, Bouchez C, et al.
J Extracell Vesicles
. 2023 Dec;
12(12):e12390.
PMID: 38117000
Nasopharyngeal carcinoma-derived small extracellular vesicles (NPCSEVs) have an immunosuppressive impact on the tumour microenvironment. In this study, we investigated their influence on the generation of tolerogenic dendritic cells and the...
6.
Quilbe A, Mustapha R, Duchene B, Kumar A, Werkmeister E, Leteurtre E, et al.
Front Immunol
. 2023 Dec;
14:1267279.
PMID: 38098486
Background: Pancreatic adenocarcinoma (PDAC) is a devastating disease with an urgent need for therapeutic innovation. Immune checkpoint inhibition has shown promise in a variety of solid tumors, but most clinical...
7.
Baydoun M, Boidin L, Leroux B, Vignion-Dewalle A, Quilbe A, Grolez G, et al.
Int J Mol Sci
. 2023 Jul;
24(14).
PMID: 37511049
Photodynamic therapy (PDT) has shown improvements in cancer treatment and in the induction of a proper anti-tumor immune response. However, current photosensitizers (PS) lack tumor specificity, resulting in reduced efficacy...
8.
An Efficient 5-Aminolevulinic Acid Photodynamic Therapy Treatment for Human Hepatocellular Carcinoma
Kumar A, Pecquenard F, Baydoun M, Quilbe A, Morales O, Leroux B, et al.
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37445603
Photodynamic therapy (PDT) is a two-stage treatment relying on cytotoxicity induced by photoexcitation of a nontoxic dye, called photosensitizer (PS). Using 5-aminolevulinic acid (5-ALA), the pro-drug of PS protoporphyrin IX,...
9.
Kumar A, Morales O, Mordon S, Delhem N, Boleslawski E
Cancers (Basel)
. 2021 Oct;
13(20).
PMID: 34680325
Photodynamic Therapy (PDT) relies on local or systemic administration of a light-sensitive dye, called photosensitizer, to accumulate into the target site followed by excitation with light of appropriate wavelength and...
10.
Milhem C, Morales O, Ingelaere C, Pasquier D, Mordon S, Mortier L, et al.
Int J Mol Sci
. 2020 Sep;
21(18).
PMID: 32942768
The development of immunotherapy has recently modified the anti-tumor therapeutic arsenal; particularly, immune checkpoint inhibitors have led to a significant increase in overall survival. The current challenge is now to...